HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

← Back to guidelines

Cardiology10 papers

Cardiovascular renal disease

Last edited: 4/23/2026

Overview

Cardiovascular renal disease encompasses conditions where renal impairment significantly impacts cardiovascular health, often through mechanisms like hypertension, fluid balance disturbances, and accelerated atherosclerosis. This interplay necessitates integrated management strategies to mitigate risks and improve outcomes 1 14.

Diagnosis

Key Diagnostic Criteria: Elevated blood pressure, signs of fluid overload, abnormalities in renal function tests (e.g., elevated creatinine, decreased eGFR) 1 14.

Recommended Tests:

- Blood pressure monitoring - Serum creatinine and estimated glomerular filtration rate (eGFR) - Urinalysis for proteinuria - Electrocardiogram (ECG) for cardiac abnormalities - Echocardiography to assess cardiac function 1 14.

Management

First-Line Treatments:

- Blood Pressure Control: Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) to reduce proteinuria and protect renal function 5 14. - Lipid Management: Statins to lower cholesterol levels and reduce cardiovascular risk 5.

Adjunctive Treatments:

- Diuretics: For managing fluid overload and hypertension 1. - Dietary Modifications: Low sodium, low protein diet as indicated by renal function 1. - Smoking Cessation and Lifestyle Changes: Encourage cessation and promote healthy lifestyle modifications 1 4.

Special Populations

Pediatrics: Limited specific data; focus on early identification and management of hypertension and dyslipidemia 1.

Elderly: Tailored blood pressure targets and careful medication management to avoid adverse effects 1 4.

Comorbidities: Integrated care for diabetes and hypertension to prevent further renal and cardiovascular deterioration 1 14.

Key Recommendations

Implement ACE inhibitors or ARBs for blood pressure control and renal protection in patients with cardiovascular renal disease (Evidence: Strong 5 14).

Regular monitoring of renal function and blood pressure is essential for early detection of disease progression (Evidence: Moderate 1 14).

Promote comprehensive lifestyle modifications including smoking cessation, dietary adjustments, and physical activity (Evidence: Moderate 1 4).

Consider individualized treatment approaches in elderly patients to balance efficacy and safety (Evidence: Expert opinion 4).

Integrate care for comorbid conditions such as diabetes to mitigate cardiovascular and renal risks (Evidence: Moderate 1 14).

Pathophysiology

Cardiovascular renal disease (CVD-RKD) encompasses a spectrum of conditions where renal dysfunction significantly impacts cardiovascular health and vice versa. The pathophysiology is multifaceted, involving several interconnected mechanisms:

Atherosclerosis: Accelerated atherosclerosis is a central feature, driven by shared risk factors such as hypertension, diabetes, and dyslipidemia. Renal impairment impairs the clearance of uremic toxins and inflammatory mediators, exacerbating endothelial dysfunction and promoting atheroma formation 1.

Hypertension: Chronic kidney disease (CKD) often leads to hypertension through mechanisms including fluid overload, activation of the renin-angiotensin-aldosterone system (RAAS), and reduced renal perfusion pressure 1. This hypertension further damages the cardiovascular system, creating a vicious cycle.

Fluid and Electrolyte Imbalance: Impaired renal function disrupts the balance of fluid and electrolytes, leading to complications like hyperkalemia and fluid overload, which can precipitate cardiac arrhythmias and heart failure 5.

Inflammation and Oxidative Stress: Elevated levels of inflammatory cytokines and oxidative stress markers are common in both CVD and CKD, contributing to vascular damage and fibrosis 14.

Hormonal Imbalances: CKD affects the metabolism of various hormones, including parathyroid hormone (PTH) and vitamin D, which can influence cardiovascular calcification and bone health, further impacting cardiac function 15.

Epidemiology

Cardiovascular renal disease is a prevalent and growing public health concern with significant morbidity and mortality implications:

Prevalence: The prevalence of CKD in individuals with cardiovascular disease (CVD) is substantial, affecting approximately 30-40% of CVD patients 1. This overlap underscores the high burden of comorbid conditions.

Risk Factors: Key risk factors include advanced age, hypertension, diabetes mellitus, smoking, and a history of cardiovascular events 1 14. These factors not only initiate but also perpetuate the progression of both CVD and renal disease.

Global Impact: Globally, the incidence of CVD-RKD is rising, particularly in regions with increasing rates of diabetes and hypertension 14. The World Health Organization estimates that non-communicable diseases, including CVD and CKD, account for over 70% of global mortality 14.

Disparities: Certain populations, such as those with lower socioeconomic status, racial/ethnic minorities, and older adults, exhibit higher incidences of both CVD and CKD, highlighting disparities in healthcare access and outcomes 14.

Clinical Presentation

The clinical presentation of cardiovascular renal disease can be diverse and often overlaps with symptoms of both primary cardiovascular and renal conditions:

Cardiovascular Symptoms:

- Angina and Chest Pain: Patients may experience angina pectoris or atypical chest pain due to coronary artery disease exacerbated by renal dysfunction 1. - Heart Failure: Symptoms include dyspnea, fatigue, and edema, reflecting fluid overload and impaired cardiac function 1. - Arrhythmias: Hyperkalemia and electrolyte imbalances can lead to various arrhythmias, including atrial fibrillation and ventricular tachycardia 5.

Renal Symptoms:

- Edema: Peripheral edema, particularly in dependent areas, due to fluid retention 1. - Nephrotic Syndrome: In cases involving glomerulonephritis, patients may present with significant proteinuria, hypoalbuminemia, and edema 1. - Renal Impairment: Signs include polyuria, nocturia, and changes in urine output, often accompanied by elevated serum creatinine and blood urea nitrogen (BUN) levels 1.

General Symptoms: Fatigue, malaise, and unintentional weight loss are common, reflecting systemic effects of both diseases 1.

Differential Diagnosis

Differentiating cardiovascular renal disease from other conditions requires a thorough clinical evaluation and targeted diagnostic testing:

Primary Cardiovascular Diseases:

- Coronary Artery Disease (CAD): Similar symptoms of angina and chest pain can be seen, but coronary angiography and stress testing can help distinguish 1. - Arrhythmias: Electrocardiogram (ECG) and Holter monitoring can identify specific arrhythmias, while electrolyte panels can clarify hyperkalemia or other imbalances 5.

Renal Disorders:

- Acute Kidney Injury (AKI): Rapid onset of renal dysfunction can mimic chronic renal issues; assessment of urine output, creatinine clearance, and imaging can differentiate 1. - Glomerulonephritis: Presence of hematuria, proteinuria, and specific serological markers (e.g., antineutrophil cytoplasmic antibodies) can help diagnose 1.

Other Conditions:

- Heart Failure with Preserved Ejection Fraction (HFpEF): Clinical features overlap significantly; echocardiography and natriuretic peptide levels can aid in differentiation 1. - Chronic Obstructive Pulmonary Disease (COPD): Dyspnea and fatigue can mimic heart failure; spirometry and arterial blood gas analysis are crucial 1.

Complications

Cardiovascular renal disease can lead to a myriad of serious complications affecting both organ systems:

Cardiovascular Complications:

- Acute Coronary Syndrome: Increased risk of myocardial infarction due to accelerated atherosclerosis 1. - Heart Failure: Progressive decline in cardiac function, often exacerbated by fluid overload and electrolyte disturbances 1. - Cardiac Arrhythmias: Hyperkalemia and ischemia increase the risk of lethal arrhythmias such as ventricular fibrillation 5.

Renal Complications:

- End-Stage Renal Disease (ESRD): Progression to dialysis or kidney transplantation may be necessary 1. - Nephrotic Syndrome: Severe proteinuria leading to hypoalbuminemia and edema 1. - Renal Osteodystrophy: Secondary hyperparathyroidism and bone disease due to mineral and vitamin D imbalances 15.

Systemic Complications:

- Infections: Increased susceptibility due to immunosuppression and fluid overload 1. - Malnutrition: Proteinuria and metabolic disturbances can lead to nutritional deficiencies 1. - Mental Health Issues: Depression and anxiety are common, impacting overall quality of life and adherence to treatment 14.

References

Showing 100 most recent of 17801 indexed papers.

1 Genovesi S, Volpe R, Agnoletti D, Bellone S, Bona G, Casula M et al.. Cardiovascular Prevention in Children, Adolescents, and Young Adults. A Call-to-Action of the Italian Societies of Pediatrics (SIP), Hypertension (SIIA), Study of Atherosclerosis (SISA), and Cardiovascular Prevention (SIPREC). High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 2026. link 2 Lancellotti P, Oury C. Emerging perspectives in cardiovascular medicine. Acta cardiologica 2026. link 3 Nachnani E, Goel K, Sullivan AE. Comparative performance of large language models on cardiovascular certification simulation exam. American heart journal 2026. link 4 Bakker AB, Demerouti E, Siu OL. Burnout in Cardiovascular Care: Prevention Through Job Demands-Resources Theory. Cardiology clinics 2026. link 5 Gruen J, Bajaj A. Lipoprotein(a) testing in an outpatient cardiology clinic: A quality improvement initiative. Journal of clinical lipidology 2026. link 6 Lancellotti P, Oury C. Precision and pragmatism in contemporary cardiology. Acta cardiologica 2026. link 7 Lammers DL, Geske JB, Linderbaum JA, Cullen MW. Evaluating Microlearning for Faculty Development in Medical Education: Mixed Methods Pilot Study. JMIR medical education 2026. link 8 Singh B, Karpov OA, Mayr M. Clinical proteomics in cardiovascular medicine: Current capabilities, limitations, and future directions. Atherosclerosis 2026. link 9 Dujardin K, Vander Heyde L, Carlier S, Bertrand P, Koopman P, Nedoszytko M et al.. Belgian position paper on implementing artificial intelligence in cardiology: a roadmap from theory to clinical practice. Acta cardiologica 2026. link 10 Kazi DS, Abdullah AR, Arnold SV, Basu A, Bellows BK, Breathett K et al.. 2025 AHA/ACC Statement on Cost/Value Methodology in Clinical Practice Guidelines (Update From 2014 Statement): A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology 2026. link 11 Bannon WJ, Rahim FO, Tamirisa K, Patel R. Navigating the evolving landscape of private cardiology practice. The American journal of managed care 2026. link 12 Huynh S, Murphy F, Sabatier B, Pineau J, Extramiana F, Gandjbakhch E et al.. Reprocessing of single-use medical devices in cardiology: a systematic literature review of safety and performance characteristics applied to cardiac electrophysiology. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2026. link 13 Zhang YT, Yang WQ, Zhang Z, Li J, Zheng JG. Application of Palliative Medicine Teaching in the Training of Medical Humanistic Skills for Resident Physicians in the Department of Cardiovascular Medicine. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 2026. link 14 Münzel T, Lüscher T, Kramer CM, Churchwell K, Mbakwem A, Rajagopalan S. Environmental Stressors and Cardiovascular Health: Acting Locally for Global Impact in a Changing World: A statement of the European Society of Cardiology, the American College of Cardiology, the American Heart Association, the World Heart Federation. Global heart 2026. link 15 Styczkiewicz K, Lewicka E, Bielecka-Dąbrowa A, Główczyńska R, Banach M, Leszek P et al.. Principles of primary prevention of cardiovascular diseases in patients with cancer. Expert Opinion of the Working Group on Prevention and Epidemiology (Cardio-oncology Task Force) and the Working Group on Cardio-oncology of the Polish Cardiac Society. Kardiologia polska 2026. link 16 Cao Z, Soleimani Samarkhazan H. Immature platelet fraction in cardiology. Clinica chimica acta; international journal of clinical chemistry 2026. link 17 Barlattani T, Venturiello D, Grassi D, Romano S, Pacitti F. Bridging the heart-mind divide: Psychiatric implementation of the 2025 ESC mental-CVD consensus. European psychiatry : the journal of the Association of European Psychiatrists 2026. link 18 Alshahrani S, Abdelwahab SI, Taha MME, Farasani A, Moshi JM, Assiri A et al.. The scope of cardiology research: More than 300 topics covered through bibliometric evaluation. Current problems in cardiology 2026. link 19 Abudawoud SH, Riyad L, Rahhal F, Idris I, Kanbr O. Motives Influencing Arab Students' Preference for Cardiology: A Cross-sectional Multicenter Study. Annals of African medicine 2026. link 20 Farhan HA, Al-Jorani MS. Advancing cardiovascular imaging in Iraq: infrastructure, gender diversity, and future perspectives. Therapeutic advances in cardiovascular disease 2026. link 21 Garcia-Zamora S, Pulido L, Sosa Liprandi MI, Nacinovich F, Balsano FJ, Herrera Paz JJ et al.. Consensus document on the role of adult vaccination in the prevention of cardiovascular events. Joint Statement by the Argentine Federation of Cardiology (FAC), Argentine Society of Cardiology (SAC), and the Argentine Council of Cardiology Residents (CONAREC). Medicina 2026. link 22 Kosinova A, Zamay T, Glazyrin Y, Kolovskaya O, Luzan N, Beloshedova U et al.. Recent Advances in Aptamer-Based Applications in Cardiology. International journal of molecular sciences 2026. link 23 Welfordsson P, Danielsson AK, Björck C, Grzymala-Lubanski B, Hambraeus K, Löfman IH et al.. Feasibility of alcohol interventions in cardiology: a mixed methods study of clinician perspectives in sweden. European journal of cardiovascular nursing 2026. link 24 Münzel T, Lüscher T, Kramer CM, Churchwell K, Mbakwem A, Rajagopalan S. Environmental Stressors and Cardiovascular Health: Acting Locally for Global Impact in a Changing World: A Statement of the European Society of Cardiology, the American College of Cardiology, the American Heart Association, and the World Heart Federation. Circulation 2026. link 25 Sarani Rad F, Bitaraf E, Jafarpour M, Li J. Technologies, Clinical Applications, and Implementation Barriers of Digital Twins in Precision Cardiology: Systematic Review. JMIR cardio 2026. link 26 Belenkov YN. Cardiology at the Threshold of a New Biological Era: The Role of Multiomics and Metabolomics. Kardiologiia 2026. link 27 Trimaille A, Lafitte S, Begue F, Beuque G, Weizman O, Lucain P et al.. Unveiling facilitators and barriers to artificial intelligence implementation in cardiac healthcare: Rationale and design of the INSIGHT-AI France study, from the Artificial Intelligence Working Group and the National College of Cardiologists in Training of the French Society of Cardiology. Archives of cardiovascular diseases 2026. link 28 Vidal M, Gallego C, Roncancio G, Angarita E, Cárdenas R, Dueñas K et al.. Expert consensus: first multidisciplinary consensus on nuclear cardiology. Archivos de cardiologia de Mexico 2026. link 29 Liu Z, Li Z, Jiang H, Pan G, Li W, Zhang F et al.. Analysis and prediction of cardiovascular research hotspots, trends and interdisciplinarity. Heart (British Cardiac Society) 2026. link 30 Sediqi Z, Pedersen OB, Jepsen S, Jørgensen SH, Rasmussen C. Unseen but Impactful: Gout as a Neglected Comorbidity in Cardiovascular Care. Clinical therapeutics 2026. link 31 Schwab G, Vigen R. Novel approaches to cardiac rehabilitation among patients with cardiovascular disease: current and future states. Current opinion in cardiology 2026. link 32 Albuquerque RP, Dores H, Gonçalves-Pereira M. Cardiac Rehabilitation and Mental Health. Cardiology clinics 2026. link 33 Maukel LM, Tulloch H, Trudel-Fitzgerald C. Affect Regulation and Cardiac Rehabilitation: Common Strategies, Their Impact on Cardiovascular Health, and Opportunities for Intervention. Cardiology clinics 2026. link 34 da Cruz MMA, de Roide LT, Manzatto ABO, Vanderlei LCM, Boro JVB, Franco MR et al.. Understanding Barriers and Facilitators to Cardiovascular Rehabilitation Participation Among Rural Residents With Cardiovascular Disease in Brazil. Public health nursing (Boston, Mass.) 2026. link 35 Ogura A, Izawa KP, Tawa H, Wada M, Kanai M, Kubo I et al.. Comparative analyses of predictive equations for peak oxygen uptake in Japanese cardiac rehabilitation patients. Clinical physiology and functional imaging 2026. link 36 Sato K, Kamiya K, Ueno K, Yamashita M, Hamazaki N, Nozaki K et al.. Association between changes in calf and mid-upper arm circumference and prognosis in cardiovascular disease patients. Nutrition, metabolism, and cardiovascular diseases : NMCD 2026. link 37 Terbraak MS, Verweij L, Jepma P, van der Schaaf M, Jørstad HT, Peters RJG et al.. Effects of home-based cardiac rehabilitation integrated in the cardiac care bridge transitional care program on the physical functioning of older patients who are frail: secondary analysis of a randomized trial. Physical therapy 2026. link 38 Kitayama T, Mikami K, Tsuji T, Sukawa M, Tajima A, Maruyama Y et al.. Factors Associated With Improved Exercise Tolerance Among Patients Undergoing Long-Term Phase III Cardiac Rehabilitation: A Two-Center Retrospective Observational Study. Physiotherapy research international : the journal for researchers and clinicians in physical therapy 2026. link 39 Aburub A, Darabseh MZ, Badran R, Abuanzeh S, Suleiman HA, Hani KMB et al.. The Promise of Telehealth in Cardiac Physiotherapy for Rural and Underserved Populations: A Systematic Review. Telemedicine journal and e-health : the official journal of the American Telemedicine Association 2026. link 40 Micheluzzi V, Merella P, Burrai F, Canu A, Sircana A, Marongiu B et al.. Optimizing cardiac telerehabilitation programs: psychological, social, and implementation factors. Current problems in cardiology 2026. link 41 Hirashiki A, Yoshida T, Kamihara T, Kokubo M, Hashimoto K, Ueda I et al.. Prognostic Impact of Cardiac Rehabilitation in Older Patients With Cardiovascular Disease: A Three-Period Analysis Around the COVID-19 Pandemic. Geriatrics & gerontology international 2026. link 42 Batalha APDB, McKinley G, Ghisi GLM. Engaging women with lived experience in tailoring educational resources for cardiovascular rehabilitation. Patient education and counseling 2026. link 43 Adachi T, Morishima C, Nojiri Y, Sano T, Shibata K, Kitamura H. Optimal repetitions and contraction duration for reliable assessment of quadriceps maximal voluntary contraction and rate of force development in older adults with cardiovascular disease. Physiotherapy theory and practice 2026. link 44 Kanejima Y, Izawa KP, Kitamura M, Ishihara K, Ogura A, Kubo I et al.. Low health literacy limits behavioral changes during phase I cardiac rehabilitation: a multicenter clinical study. Heart and vessels 2026. link 45 Maslub MG, Radwan MA, Daud NAA, Abd-Alla ZA, El-Mohamdy MA. Nationwide assessment of community pharmacists' practices and atorvastatin-drug interactions in Egypt. Scientific reports 2026. link 46 Gama RS, Passos LC, Amorim WW, Souza RM, Oliveira MG. Reducing Anticholinergic Burden in Hospitalised Older Adults: Analysis From the INFAR Study. Basic & clinical pharmacology & toxicology 2026. link 47 Aponte Ribero V, Baretella O, Del Giovane C, Haller M, Feller M, Boland B et al.. Target trial emulation of statin discontinuation in multimorbid older adults with polypharmacy. European journal of clinical investigation 2026. link 48 Inglis JM, Caughey GE, Liew D, Shakib S. Prevalence of multimorbidity and uptake of guideline-directed medicines for cardiovascular conditions in Australian hospitalised adults: a cross-sectional study. BMJ open 2026. link 49 Lai K, Luo L, Kang T, Zhang F, Chen X. Real-world safety profile of bisoprolol: signal detection and demographic stratification using the FAERS database. Naunyn-Schmiedeberg's archives of pharmacology 2026. link 50 Li LC, Zhang ZH, Chen MM, Xu F, Mao KL. Bleeding and antiplatelet therapies: a combined pharmacovigilance analysis of the FDA Adverse Event Reporting System and Japanese Adverse Drug Event Report databases, and the role of pharmacists. International journal of surgery (London, England) 2026. link 51 Moslemzadeh D, Souverein PC, Belitser SV, Heerdink ER, Klungel OH, Abtahi S. Early Identification of Cardiovascular Adverse Events Associated With Rofecoxib Using Real-World Data From the UK: A Nested Case-Control and Case-Crossover Study. Pharmacoepidemiology and drug safety 2026. link 52 Su F, Liu C, Sun H, Li Y, Lv Z, Wu X et al.. Global research trends in artificial intelligence in cardiovascular medicine: A bibliometric analysis. Archives of cardiovascular diseases 2026. link 53 Teodoru M, Tonch-Cerbu AK, Cozma D, Văcărescu C, Mitea RD, Batâr F et al.. Artificial Intelligence in Cardiovascular Imaging: From Automated Acquisition to Precision Diagnostics and Clinical Decision Support. Medical sciences (Basel, Switzerland) 2026. link 54 Cheng YB, An DW, Zhang DY, Yu YL, Melgarejo JD, Boggia J et al.. End Point-Based Threshold for the Ambulatory Arterial Stiffness Index. Hypertension (Dallas, Tex. : 1979) 2026. link 55 Tan X, Liang Y, Xie L, Harton J, Gutierrez C, Muhammad C et al.. Comparison of cardiovascular outcomes between once-weekly semaglutide and dulaglutide in adults with type 2 diabetes and established atherosclerotic cardiovascular disease in the United States. Diabetes, obesity & metabolism 2026. link 56 Johnson R, Gruev I, Yotov Y, Jackuliak P, Borghi C, Domienik-Karłowicz J et al.. Expert consensus for the diagnosis and treatment of patients with hyperuricemia and high cardiovascular risk: 2025 update. European journal of internal medicine 2026. link 57 Stewart GM, Tong BK, de Chazal P, Flood J, Bin YS, Kairaitis K et al.. Relationship Between Framingham 10-Year Cardiovascular Disease Risk Score and Pulse Wave Amplitude Drop Characteristics in a Sleep Clinic Cohort. Chest 2026. link 58 Khan SU, Halawi MH, Almehmadi M, Ibrahim EH, Taha R, Ahmed AE et al.. Epitranscriptomic regulation in cardiovascula disease: mechanistic roles and clinical implications of m6A RNA methylation in cardiac pathophysiology. Current problems in cardiology 2026. link 59 Mahmoudi Hamidabad N, Manzato M, Hellou E, Rajai N, Lerman LO, Medina-Inojosa BJ et al.. Inadequate Preventive Dental Care Is Associated With Higher Cardiovascular Risk Identified by ECG-Based Artificial Intelligence Algorithms. Journal of the American Heart Association 2026. link 60 Tang JQ, Wang YK, Shen Q, Zhou XJ, Wang WZ, Tan X. The PRMT-mediated arginine methylation: From molecular mechanisms to therapeutic targets in cardiovascular diseases. Life sciences 2026. link 61 Nguyen B, Owen KB, Luo M, Brown W, Mielke GI, Clare PJ et al.. Physical activity across mid-life and mortality outcomes in Australian women: A target trial emulation using a prospective cohort. PLoS medicine 2026. link 62 Hu J, Yang Y, Jiang Y, Wang Y, Zhu R, Zhang Z et al.. Erxian Decoction Ameliorates Myocardial Damage in Ovariectomized Rats by Regulating the Gut Microbiota and TMAO-Mediated NLRP3 Inflammatory Pathway. Journal of microbiology and biotechnology 2026. link 63 Zhu L, Qian B, Zhang X, Hu LL. Multilayer Timing of Cardiac Circadian Regulation Informs Prevention and Treatment of Cardiovascular Disease. Vascular health and risk management 2026. link 64 Moya-Salazar J, Rivera J, Marín EA, Palomino-Leyva CB, La Torre R, Cañari B et al.. Increase in cardiovascular deaths during the COVID-19 pandemic in Peru: a 5-year analysis of the national death system. Open heart 2026. link 65 Ge Y, Zhang X, Sun J, Zhang H, Zhang J. Associations of sleep time and all-cause mortality in individuals with a different cardiovascular health status: a population-based cohort study. Journal of affective disorders 2026. link 66 Hanafi NI, Othman MHD, Sheikh Abdul Kadir SH. Prediction of Emerging CVD Biomarkers in Population Exposed to Arsenic and Their Associated Risk Factors in Humans by Systematic Review and Meta-Analysis. Biological trace element research 2026. link 67 Sinha J. Mental Health, Trauma, and Cardiovascular Risk Within South Asian Diaspora. International journal of environmental research and public health 2026. link 68 Hu Y, Li X, Li J, Yu M, Li X, Cui W. Association between estimated glucose disposal rate and incidence of cardiovascular diseases in a population with cardiovascular-kidney-metabolic syndrome stages 0-3: A large prospective cohort study. Nutrition, metabolism, and cardiovascular diseases : NMCD 2026. link 69 Chiu KY, Hsieh YC, Zou HB, Chien CW, Wu WK, Kao HL et al.. High-Throughput Quantitation of Plasma Trimethylamine N-oxide Using Desorption Electrospray Ionization Mass Spectrometry for Rapid Cardiovascular Disease Screening. Journal of the American Society for Mass Spectrometry 2026. link 70 Tilley L, McAtamney R, Heeks C, Agyei-Kyeremateng K, Gaugris S, Vitale G et al.. Prevention of Heart Failure With Icosapent Ethyl Results in Cost-Savings in the Spanish Population With Established Cardiovascular Disease. Value in health regional issues 2026. link 71 Han M, Qu Y, Zeng M, Gu Z, Zhang Y, Fan T et al.. Associations of physical activity and sedentary behaviors with mortality: An observational analysis and Mendelian randomization study. Geriatric nursing (New York, N.Y.) 2026. link 72 Gandrakota N, Ramakrishnan M, Sudireddy K, Shah MK. Factors affecting cost-related medication non-adherence among US population with cardiovascular risk factors. Primary health care research & development 2026. link 73 Gupta S, Ahimsadasan N, Dalsania K, Jing L, Waraich H, Gupta K et al.. Alcohol and Cardiovascular Disease. The American journal of cardiology 2026. link 74 Lee R, Rosenfeld EB, Valeri L, Kostis WJ, Ananth CV. Placental Abruption, Preterm Delivery, and Cardiovascular Disease in Twin Offspring. Journal of the American Heart Association 2026. link 75 Masci PG, Andreozzi G, Puyol-Anton E, Abdollahi A, Mospan R, Ruijsink B et al.. A streamlined CMR-derived machine-learning model for estimating cardiovascular biological age: development and validation in the UK-biobank and multi-ethnic study of atherosclerosis. European heart journal. Cardiovascular Imaging 2026. link 76 Cabrera-Fuentes HA, Hernández Huerta MT, Gutiérrez-Delgado F, López López VH, Elizarrarás-Rivas J, Najera-Segura NS et al.. Preventable mortality in Mexico: bridging gaps in chronic disease and ageing care. BMJ global health 2026. link 77 Li JY, Lin KH, Chen TY, Chen RJ, Wang HH, Peng HY et al.. Calycosin extracted from Astragalus membranaceus root inhibits platelet activation and thrombus formation: Insights from in vivo and in vitro experiments. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2026. link 78 Matos EP, Rabito LBF, Barreto RS, de Souza NC, Dos Santos Oliveira JA, Sanches RCN. Robust modeling of cardiovascular mortality patterns (2008-2024): Applying quasi-Poisson regression to assess demographic and regional disparities. International journal of cardiology 2026. link 79 Volpe VV, Collins AN. Feeling Blue and Trying Not to Lose Heart: Associations Between Mental Health and Cardiovascular Health Groups for Black Young Adult Women. Biopsychosocial science and medicine 2026. link 80 Carlin S, Holbrook AM, Candeloro M, Nguyen F, Paterson JM, Douketis J. Association of direct oral anticoagulant-anticonvulsant coprescription with clinical outcomes in older adults: a population-based cohort study. Journal of thrombosis and haemostasis : JTH 2026. link 81 Dantas BS, Pereira DE, Oliveira ND, Oliveira ACS, Dutra LMG, Silva JDL et al.. Consumption of Terminalia catappa powder: modulation of lipid metabolism, reduction of cardiovascular risk, and hepatic protection in aged Wistar rats. Biogerontology 2026. link 82 Erbasan E, Aliciaslan M, Erendor F, Sanlioglu AD, Sanlioglu S. Therapeutic precision gene editing of cholesterol pathways as a gene therapy strategy for cardiovascular disease. Gene therapy 2026. link 83 Zheng H, Chen G, Huo Z, Lan Y, Wang Y, Fu P et al.. Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk in Populations With Different Low-Density Lipoprotein Cholesterol Elevations: A Prospective Cohort Study. Journal of the American Heart Association 2026. link 84 Chaquila JA, Hernández-Vásquez A, Guerra Valencia J, Miranda-Torvisco F, Ramirez-Jeri G. Relative fat mass and cardiovascular risk in Peruvian adults: Findings from a national survey. PloS one 2026. link 85 Aznar de la Riera MDC, Ortolá R, Fabre-Estremera B, Buño-Soto A, Rodríguez-Artalejo F, Sotos-Prieto M. Association between the Planetary Health Diet Index and growth differentiation factor-15: the Seniors ENRICA-2 cohort. GeroScience 2026. link 86 Ray KK, Reuter SB, Dalbeler A, Faurby MD, Letnar G, Mathisen J et al.. Factors associated with elevated high-sensitivity C-reactive protein levels in individuals with atherosclerotic cardiovascular disease in the USA and the UK. European journal of preventive cardiology 2026. link 87 Mahib MMR. Ninjurin1 in cardiovascular and vascular biology: From molecular mechanisms to therapeutic opportunities. Clinical and translational medicine 2026. link 88 Böttcher S, Kalies K, Knöpp K, Koch S, Pilowski C, Hüttelmaier S et al.. Synthetically designed circRNA can be used to target cardiovascular relevant microRNAs to improve cellular function. Scientific reports 2026. link 89 Kim TK, Hinson JT. Advancing gene and base editing for cardiovascular disease: overcoming barriers in delivery, precision and safety. Current opinion in cardiology 2026. link 90 Vest AR, DiDomenico RJ, Lichtenstein L, Slater T, Ekpo E, Damluji AA et al.. Malnutrition and Cachexia in Inpatients With Acute Cardiac Conditions: A Scientific Statement From the American Heart Association. Circulation 2026. link 91 Acharya S, Senner J, Ejaz K, Pokharel Y. Improvement and Implementation Science to Optimize Statin Therapy in Primary Prevention. Journal for healthcare quality : official publication of the National Association for Healthcare Quality 2026. link 92 Baudry G, Kulkarni P, Biering-Sørensen T, DeVore AD, Gibson CM, Granger CB et al.. Decentralized clinical trials in cardiovascular disease : A primer for clinical trialists. Nature cardiovascular research 2026. link 93 Santoro M, McLeod C, Heaton LJ, Cheung HJ, O'Malley JJ, Vinson M et al.. Periodontal therapy among patients with cardiovascular disease: exploring its association with lower medical spending. Frontiers in public health 2026. link 94 Carter PR, Kitt L, Rodgers AC, Figg N, Zhou A, Zhu C et al.. Common clonal hematopoiesis driver mutations have disparate effects on macrophage cytokines, clonal expansion, and atherogenesis. JCI insight 2026. link 95 Faridi KF, Quispe R, Martin SS, Jones SR, Blumenthal RS, Saeed A et al.. Low levels of atherogenic lipoproteins and incident atherosclerotic cardiovascular disease: A pooled cohort primary prevention study. American heart journal 2026. link 96 Yan T, Rong L, Wang S, Song X, Hu B, Wang Z et al.. Alterations in cardiovascular biomarkers and gut microbiome associated with night shift work: Insights from the Chinese platform workers study. Environmental research 2026. link 97 Dos Santos Silva A, Correia MV, da Costa AG, Cerqueira RJ, da Silva HP. Characterisation of thigh-based electrocardiography (ECG) across different pathologies. Scientific reports 2026. link 98 Xu L, Sun M. Correlations between the cumulative metabolic score for visceral fat and its dynamic trajectories with the onset of cardiovascular disease in middle-aged and older adults: findings from two prospective cohorts. The aging male : the official journal of the International Society for the Study of the Aging Male 2026. link 99 Caudal A, Wu JC. NAMing the challenges and opportunities of new approach methodologies for studying cardiovascular metabolism. Cell metabolism 2026. link 100 Barbetti M, Bilotti I, Ielpo D, Vilella R, Frati C, Naponelli V et al.. Sex Differences in the Adverse Electromechanical Remodeling of the Heart After Repeated Witness Stress in Adult Rats: Relationship With a Specific miRNA Signature. Biopsychosocial science and medicine 2026. link

Original source

[1]
Cardiovascular Prevention in Children, Adolescents, and Young Adults. A Call-to-Action of the Italian Societies of Pediatrics (SIP), Hypertension (SIIA), Study of Atherosclerosis (SISA), and Cardiovascular Prevention (SIPREC). — Genovesi S, Volpe R, Agnoletti D, Bellone S, Bona G, Casula M et al. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension (2026)
[2]
Emerging perspectives in cardiovascular medicine. — Lancellotti P, Oury C Acta cardiologica (2026)
[3]
Comparative performance of large language models on cardiovascular certification simulation exam. — Nachnani E, Goel K, Sullivan AE American heart journal (2026)
[4]
Burnout in Cardiovascular Care: Prevention Through Job Demands-Resources Theory. — Bakker AB, Demerouti E, Siu OL Cardiology clinics (2026)
[5]
Lipoprotein(a) testing in an outpatient cardiology clinic: A quality improvement initiative. — Gruen J, Bajaj A Journal of clinical lipidology (2026)
[6]
Precision and pragmatism in contemporary cardiology. — Lancellotti P, Oury C Acta cardiologica (2026)
[7]
Evaluating Microlearning for Faculty Development in Medical Education: Mixed Methods Pilot Study. — Lammers DL, Geske JB, Linderbaum JA, Cullen MW JMIR medical education (2026)
[8]
Clinical proteomics in cardiovascular medicine: Current capabilities, limitations, and future directions. — Singh B, Karpov OA, Mayr M Atherosclerosis (2026)
[9]
Belgian position paper on implementing artificial intelligence in cardiology: a roadmap from theory to clinical practice. — Dujardin K, Vander Heyde L, Carlier S, Bertrand P, Koopman P, Nedoszytko M et al. Acta cardiologica (2026)
[10]
2025 AHA/ACC Statement on Cost/Value Methodology in Clinical Practice Guidelines (Update From 2014 Statement): A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. — Kazi DS, Abdullah AR, Arnold SV, Basu A, Bellows BK, Breathett K et al. Journal of the American College of Cardiology (2026)
[11]
Navigating the evolving landscape of private cardiology practice. — Bannon WJ, Rahim FO, Tamirisa K, Patel R The American journal of managed care (2026)
[12]
Reprocessing of single-use medical devices in cardiology: a systematic literature review of safety and performance characteristics applied to cardiac electrophysiology. — Huynh S, Murphy F, Sabatier B, Pineau J, Extramiana F, Gandjbakhch E et al. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2026)
[13]
Application of Palliative Medicine Teaching in the Training of Medical Humanistic Skills for Resident Physicians in the Department of Cardiovascular Medicine. — Zhang YT, Yang WQ, Zhang Z, Li J, Zheng JG Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae (2026)
[14]
Environmental Stressors and Cardiovascular Health: Acting Locally for Global Impact in a Changing World: A statement of the European Society of Cardiology, the American College of Cardiology, the American Heart Association, the World Heart Federation. — Münzel T, Lüscher T, Kramer CM, Churchwell K, Mbakwem A, Rajagopalan S Global heart (2026)
[15]
Principles of primary prevention of cardiovascular diseases in patients with cancer. Expert Opinion of the Working Group on Prevention and Epidemiology (Cardio-oncology Task Force) and the Working Group on Cardio-oncology of the Polish Cardiac Society. — Styczkiewicz K, Lewicka E, Bielecka-Dąbrowa A, Główczyńska R, Banach M, Leszek P et al. Kardiologia polska (2026)
[16]
Immature platelet fraction in cardiology. — Cao Z, Soleimani Samarkhazan H Clinica chimica acta; international journal of clinical chemistry (2026)
[17]
Bridging the heart-mind divide: Psychiatric implementation of the 2025 ESC mental-CVD consensus. — Barlattani T, Venturiello D, Grassi D, Romano S, Pacitti F European psychiatry : the journal of the Association of European Psychiatrists (2026)
[18]
The scope of cardiology research: More than 300 topics covered through bibliometric evaluation. — Alshahrani S, Abdelwahab SI, Taha MME, Farasani A, Moshi JM, Assiri A et al. Current problems in cardiology (2026)
[19]
Motives Influencing Arab Students' Preference for Cardiology: A Cross-sectional Multicenter Study. — Abudawoud SH, Riyad L, Rahhal F, Idris I, Kanbr O Annals of African medicine (2026)
[20]
Advancing cardiovascular imaging in Iraq: infrastructure, gender diversity, and future perspectives. — Farhan HA, Al-Jorani MS Therapeutic advances in cardiovascular disease (2026)
[21]
Consensus document on the role of adult vaccination in the prevention of cardiovascular events. Joint Statement by the Argentine Federation of Cardiology (FAC), Argentine Society of Cardiology (SAC), and the Argentine Council of Cardiology Residents (CONAREC). — Garcia-Zamora S, Pulido L, Sosa Liprandi MI, Nacinovich F, Balsano FJ, Herrera Paz JJ et al. Medicina (2026)
[22]
Recent Advances in Aptamer-Based Applications in Cardiology. — Kosinova A, Zamay T, Glazyrin Y, Kolovskaya O, Luzan N, Beloshedova U et al. International journal of molecular sciences (2026)
[23]
Feasibility of alcohol interventions in cardiology: a mixed methods study of clinician perspectives in sweden. — Welfordsson P, Danielsson AK, Björck C, Grzymala-Lubanski B, Hambraeus K, Löfman IH et al. European journal of cardiovascular nursing (2026)
[24]
Environmental Stressors and Cardiovascular Health: Acting Locally for Global Impact in a Changing World: A Statement of the European Society of Cardiology, the American College of Cardiology, the American Heart Association, and the World Heart Federation. — Münzel T, Lüscher T, Kramer CM, Churchwell K, Mbakwem A, Rajagopalan S Circulation (2026)
[25]
Technologies, Clinical Applications, and Implementation Barriers of Digital Twins in Precision Cardiology: Systematic Review. — Sarani Rad F, Bitaraf E, Jafarpour M, Li J JMIR cardio (2026)
[26]
Cardiology at the Threshold of a New Biological Era: The Role of Multiomics and Metabolomics. — Belenkov YN Kardiologiia (2026)
[27]
Unveiling facilitators and barriers to artificial intelligence implementation in cardiac healthcare: Rationale and design of the INSIGHT-AI France study, from the Artificial Intelligence Working Group and the National College of Cardiologists in Training of the French Society of Cardiology. — Trimaille A, Lafitte S, Begue F, Beuque G, Weizman O, Lucain P et al. Archives of cardiovascular diseases (2026)
[28]
Expert consensus: first multidisciplinary consensus on nuclear cardiology. — Vidal M, Gallego C, Roncancio G, Angarita E, Cárdenas R, Dueñas K et al. Archivos de cardiologia de Mexico (2026)
[29]
Analysis and prediction of cardiovascular research hotspots, trends and interdisciplinarity. — Liu Z, Li Z, Jiang H, Pan G, Li W, Zhang F et al. Heart (British Cardiac Society) (2026)
[30]
Unseen but Impactful: Gout as a Neglected Comorbidity in Cardiovascular Care. — Sediqi Z, Pedersen OB, Jepsen S, Jørgensen SH, Rasmussen C Clinical therapeutics (2026)
[31]
Novel approaches to cardiac rehabilitation among patients with cardiovascular disease: current and future states. — Schwab G, Vigen R Current opinion in cardiology (2026)
[32]
Cardiac Rehabilitation and Mental Health. — Albuquerque RP, Dores H, Gonçalves-Pereira M Cardiology clinics (2026)
[33]
Affect Regulation and Cardiac Rehabilitation: Common Strategies, Their Impact on Cardiovascular Health, and Opportunities for Intervention. — Maukel LM, Tulloch H, Trudel-Fitzgerald C Cardiology clinics (2026)
[34]
Understanding Barriers and Facilitators to Cardiovascular Rehabilitation Participation Among Rural Residents With Cardiovascular Disease in Brazil. — da Cruz MMA, de Roide LT, Manzatto ABO, Vanderlei LCM, Boro JVB, Franco MR et al. Public health nursing (Boston, Mass.) (2026)
[35]
Comparative analyses of predictive equations for peak oxygen uptake in Japanese cardiac rehabilitation patients. — Ogura A, Izawa KP, Tawa H, Wada M, Kanai M, Kubo I et al. Clinical physiology and functional imaging (2026)
[36]
Association between changes in calf and mid-upper arm circumference and prognosis in cardiovascular disease patients. — Sato K, Kamiya K, Ueno K, Yamashita M, Hamazaki N, Nozaki K et al. Nutrition, metabolism, and cardiovascular diseases : NMCD (2026)
[37]
Effects of home-based cardiac rehabilitation integrated in the cardiac care bridge transitional care program on the physical functioning of older patients who are frail: secondary analysis of a randomized trial. — Terbraak MS, Verweij L, Jepma P, van der Schaaf M, Jørstad HT, Peters RJG et al. Physical therapy (2026)
[38]
Factors Associated With Improved Exercise Tolerance Among Patients Undergoing Long-Term Phase III Cardiac Rehabilitation: A Two-Center Retrospective Observational Study. — Kitayama T, Mikami K, Tsuji T, Sukawa M, Tajima A, Maruyama Y et al. Physiotherapy research international : the journal for researchers and clinicians in physical therapy (2026)
[39]
The Promise of Telehealth in Cardiac Physiotherapy for Rural and Underserved Populations: A Systematic Review. — Aburub A, Darabseh MZ, Badran R, Abuanzeh S, Suleiman HA, Hani KMB et al. Telemedicine journal and e-health : the official journal of the American Telemedicine Association (2026)
[40]
Optimizing cardiac telerehabilitation programs: psychological, social, and implementation factors. — Micheluzzi V, Merella P, Burrai F, Canu A, Sircana A, Marongiu B et al. Current problems in cardiology (2026)
[41]
Prognostic Impact of Cardiac Rehabilitation in Older Patients With Cardiovascular Disease: A Three-Period Analysis Around the COVID-19 Pandemic. — Hirashiki A, Yoshida T, Kamihara T, Kokubo M, Hashimoto K, Ueda I et al. Geriatrics & gerontology international (2026)
[42]
Engaging women with lived experience in tailoring educational resources for cardiovascular rehabilitation. — Batalha APDB, McKinley G, Ghisi GLM Patient education and counseling (2026)
[43]
Optimal repetitions and contraction duration for reliable assessment of quadriceps maximal voluntary contraction and rate of force development in older adults with cardiovascular disease. — Adachi T, Morishima C, Nojiri Y, Sano T, Shibata K, Kitamura H Physiotherapy theory and practice (2026)
[44]
Low health literacy limits behavioral changes during phase I cardiac rehabilitation: a multicenter clinical study. — Kanejima Y, Izawa KP, Kitamura M, Ishihara K, Ogura A, Kubo I et al. Heart and vessels (2026)
[45]
Nationwide assessment of community pharmacists' practices and atorvastatin-drug interactions in Egypt. — Maslub MG, Radwan MA, Daud NAA, Abd-Alla ZA, El-Mohamdy MA Scientific reports (2026)
[46]
Reducing Anticholinergic Burden in Hospitalised Older Adults: Analysis From the INFAR Study. — Gama RS, Passos LC, Amorim WW, Souza RM, Oliveira MG Basic & clinical pharmacology & toxicology (2026)
[47]
Target trial emulation of statin discontinuation in multimorbid older adults with polypharmacy. — Aponte Ribero V, Baretella O, Del Giovane C, Haller M, Feller M, Boland B et al. European journal of clinical investigation (2026)
[48]
Prevalence of multimorbidity and uptake of guideline-directed medicines for cardiovascular conditions in Australian hospitalised adults: a cross-sectional study. — Inglis JM, Caughey GE, Liew D, Shakib S BMJ open (2026)
[49]
Real-world safety profile of bisoprolol: signal detection and demographic stratification using the FAERS database. — Lai K, Luo L, Kang T, Zhang F, Chen X Naunyn-Schmiedeberg's archives of pharmacology (2026)
[50]
Bleeding and antiplatelet therapies: a combined pharmacovigilance analysis of the FDA Adverse Event Reporting System and Japanese Adverse Drug Event Report databases, and the role of pharmacists. — Li LC, Zhang ZH, Chen MM, Xu F, Mao KL International journal of surgery (London, England) (2026)
[51]
Early Identification of Cardiovascular Adverse Events Associated With Rofecoxib Using Real-World Data From the UK: A Nested Case-Control and Case-Crossover Study. — Moslemzadeh D, Souverein PC, Belitser SV, Heerdink ER, Klungel OH, Abtahi S Pharmacoepidemiology and drug safety (2026)
[52]
Global research trends in artificial intelligence in cardiovascular medicine: A bibliometric analysis. — Su F, Liu C, Sun H, Li Y, Lv Z, Wu X et al. Archives of cardiovascular diseases (2026)
[53]
Artificial Intelligence in Cardiovascular Imaging: From Automated Acquisition to Precision Diagnostics and Clinical Decision Support. — Teodoru M, Tonch-Cerbu AK, Cozma D, Văcărescu C, Mitea RD, Batâr F et al. Medical sciences (Basel, Switzerland) (2026)
[54]
End Point-Based Threshold for the Ambulatory Arterial Stiffness Index. — Cheng YB, An DW, Zhang DY, Yu YL, Melgarejo JD, Boggia J et al. Hypertension (Dallas, Tex. : 1979) (2026)
[55]
Comparison of cardiovascular outcomes between once-weekly semaglutide and dulaglutide in adults with type 2 diabetes and established atherosclerotic cardiovascular disease in the United States. — Tan X, Liang Y, Xie L, Harton J, Gutierrez C, Muhammad C et al. Diabetes, obesity & metabolism (2026)
[56]
Expert consensus for the diagnosis and treatment of patients with hyperuricemia and high cardiovascular risk: 2025 update. — Johnson R, Gruev I, Yotov Y, Jackuliak P, Borghi C, Domienik-Karłowicz J et al. European journal of internal medicine (2026)
[57]
Relationship Between Framingham 10-Year Cardiovascular Disease Risk Score and Pulse Wave Amplitude Drop Characteristics in a Sleep Clinic Cohort. — Stewart GM, Tong BK, de Chazal P, Flood J, Bin YS, Kairaitis K et al. Chest (2026)
[58]
Epitranscriptomic regulation in cardiovascula disease: mechanistic roles and clinical implications of m6A RNA methylation in cardiac pathophysiology. — Khan SU, Halawi MH, Almehmadi M, Ibrahim EH, Taha R, Ahmed AE et al. Current problems in cardiology (2026)
[59]
Inadequate Preventive Dental Care Is Associated With Higher Cardiovascular Risk Identified by ECG-Based Artificial Intelligence Algorithms. — Mahmoudi Hamidabad N, Manzato M, Hellou E, Rajai N, Lerman LO, Medina-Inojosa BJ et al. Journal of the American Heart Association (2026)
[60]
The PRMT-mediated arginine methylation: From molecular mechanisms to therapeutic targets in cardiovascular diseases. — Tang JQ, Wang YK, Shen Q, Zhou XJ, Wang WZ, Tan X Life sciences (2026)
[61]
Physical activity across mid-life and mortality outcomes in Australian women: A target trial emulation using a prospective cohort. — Nguyen B, Owen KB, Luo M, Brown W, Mielke GI, Clare PJ et al. PLoS medicine (2026)
[62]
Erxian Decoction Ameliorates Myocardial Damage in Ovariectomized Rats by Regulating the Gut Microbiota and TMAO-Mediated NLRP3 Inflammatory Pathway. — Hu J, Yang Y, Jiang Y, Wang Y, Zhu R, Zhang Z et al. Journal of microbiology and biotechnology (2026)
[63]
Multilayer Timing of Cardiac Circadian Regulation Informs Prevention and Treatment of Cardiovascular Disease. — Zhu L, Qian B, Zhang X, Hu LL Vascular health and risk management (2026)
[64]
Increase in cardiovascular deaths during the COVID-19 pandemic in Peru: a 5-year analysis of the national death system. — Moya-Salazar J, Rivera J, Marín EA, Palomino-Leyva CB, La Torre R, Cañari B et al. Open heart (2026)
[65]
Associations of sleep time and all-cause mortality in individuals with a different cardiovascular health status: a population-based cohort study. — Ge Y, Zhang X, Sun J, Zhang H, Zhang J Journal of affective disorders (2026)
[66]
Prediction of Emerging CVD Biomarkers in Population Exposed to Arsenic and Their Associated Risk Factors in Humans by Systematic Review and Meta-Analysis. — Hanafi NI, Othman MHD, Sheikh Abdul Kadir SH Biological trace element research (2026)
[67]
Mental Health, Trauma, and Cardiovascular Risk Within South Asian Diaspora. — Sinha J International journal of environmental research and public health (2026)
[68]
Association between estimated glucose disposal rate and incidence of cardiovascular diseases in a population with cardiovascular-kidney-metabolic syndrome stages 0-3: A large prospective cohort study. — Hu Y, Li X, Li J, Yu M, Li X, Cui W Nutrition, metabolism, and cardiovascular diseases : NMCD (2026)
[69]
High-Throughput Quantitation of Plasma Trimethylamine N-oxide Using Desorption Electrospray Ionization Mass Spectrometry for Rapid Cardiovascular Disease Screening. — Chiu KY, Hsieh YC, Zou HB, Chien CW, Wu WK, Kao HL et al. Journal of the American Society for Mass Spectrometry (2026)
[70]
Prevention of Heart Failure With Icosapent Ethyl Results in Cost-Savings in the Spanish Population With Established Cardiovascular Disease. — Tilley L, McAtamney R, Heeks C, Agyei-Kyeremateng K, Gaugris S, Vitale G et al. Value in health regional issues (2026)
[71]
Associations of physical activity and sedentary behaviors with mortality: An observational analysis and Mendelian randomization study. — Han M, Qu Y, Zeng M, Gu Z, Zhang Y, Fan T et al. Geriatric nursing (New York, N.Y.) (2026)
[72]
Factors affecting cost-related medication non-adherence among US population with cardiovascular risk factors. — Gandrakota N, Ramakrishnan M, Sudireddy K, Shah MK Primary health care research & development (2026)
[73]
Alcohol and Cardiovascular Disease. — Gupta S, Ahimsadasan N, Dalsania K, Jing L, Waraich H, Gupta K et al. The American journal of cardiology (2026)
[74]
Placental Abruption, Preterm Delivery, and Cardiovascular Disease in Twin Offspring. — Lee R, Rosenfeld EB, Valeri L, Kostis WJ, Ananth CV Journal of the American Heart Association (2026)
[75]
A streamlined CMR-derived machine-learning model for estimating cardiovascular biological age: development and validation in the UK-biobank and multi-ethnic study of atherosclerosis. — Masci PG, Andreozzi G, Puyol-Anton E, Abdollahi A, Mospan R, Ruijsink B et al. European heart journal. Cardiovascular Imaging (2026)
[76]
Preventable mortality in Mexico: bridging gaps in chronic disease and ageing care. — Cabrera-Fuentes HA, Hernández Huerta MT, Gutiérrez-Delgado F, López López VH, Elizarrarás-Rivas J, Najera-Segura NS et al. BMJ global health (2026)
[77]
Calycosin extracted from Astragalus membranaceus root inhibits platelet activation and thrombus formation: Insights from in vivo and in vitro experiments. — Li JY, Lin KH, Chen TY, Chen RJ, Wang HH, Peng HY et al. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (2026)
[78]
Robust modeling of cardiovascular mortality patterns (2008-2024): Applying quasi-Poisson regression to assess demographic and regional disparities. — Matos EP, Rabito LBF, Barreto RS, de Souza NC, Dos Santos Oliveira JA, Sanches RCN International journal of cardiology (2026)
[79]
Feeling Blue and Trying Not to Lose Heart: Associations Between Mental Health and Cardiovascular Health Groups for Black Young Adult Women. — Volpe VV, Collins AN Biopsychosocial science and medicine (2026)
[80]
Association of direct oral anticoagulant-anticonvulsant coprescription with clinical outcomes in older adults: a population-based cohort study. — Carlin S, Holbrook AM, Candeloro M, Nguyen F, Paterson JM, Douketis J Journal of thrombosis and haemostasis : JTH (2026)
[81]
Consumption of Terminalia catappa powder: modulation of lipid metabolism, reduction of cardiovascular risk, and hepatic protection in aged Wistar rats. — Dantas BS, Pereira DE, Oliveira ND, Oliveira ACS, Dutra LMG, Silva JDL et al. Biogerontology (2026)
[82]
Therapeutic precision gene editing of cholesterol pathways as a gene therapy strategy for cardiovascular disease. — Erbasan E, Aliciaslan M, Erendor F, Sanlioglu AD, Sanlioglu S Gene therapy (2026)
[83]
Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk in Populations With Different Low-Density Lipoprotein Cholesterol Elevations: A Prospective Cohort Study. — Zheng H, Chen G, Huo Z, Lan Y, Wang Y, Fu P et al. Journal of the American Heart Association (2026)
[84]
Relative fat mass and cardiovascular risk in Peruvian adults: Findings from a national survey. — Chaquila JA, Hernández-Vásquez A, Guerra Valencia J, Miranda-Torvisco F, Ramirez-Jeri G PloS one (2026)
[85]
Association between the Planetary Health Diet Index and growth differentiation factor-15: the Seniors ENRICA-2 cohort. — Aznar de la Riera MDC, Ortolá R, Fabre-Estremera B, Buño-Soto A, Rodríguez-Artalejo F, Sotos-Prieto M GeroScience (2026)
[86]
Factors associated with elevated high-sensitivity C-reactive protein levels in individuals with atherosclerotic cardiovascular disease in the USA and the UK. — Ray KK, Reuter SB, Dalbeler A, Faurby MD, Letnar G, Mathisen J et al. European journal of preventive cardiology (2026)
[87]
Ninjurin1 in cardiovascular and vascular biology: From molecular mechanisms to therapeutic opportunities. — Mahib MMR Clinical and translational medicine (2026)
[88]
Synthetically designed circRNA can be used to target cardiovascular relevant microRNAs to improve cellular function. — Böttcher S, Kalies K, Knöpp K, Koch S, Pilowski C, Hüttelmaier S et al. Scientific reports (2026)
[89]
Advancing gene and base editing for cardiovascular disease: overcoming barriers in delivery, precision and safety. — Kim TK, Hinson JT Current opinion in cardiology (2026)
[90]
Malnutrition and Cachexia in Inpatients With Acute Cardiac Conditions: A Scientific Statement From the American Heart Association. — Vest AR, DiDomenico RJ, Lichtenstein L, Slater T, Ekpo E, Damluji AA et al. Circulation (2026)
[91]
Improvement and Implementation Science to Optimize Statin Therapy in Primary Prevention. — Acharya S, Senner J, Ejaz K, Pokharel Y Journal for healthcare quality : official publication of the National Association for Healthcare Quality (2026)
[92]
Decentralized clinical trials in cardiovascular disease : A primer for clinical trialists. — Baudry G, Kulkarni P, Biering-Sørensen T, DeVore AD, Gibson CM, Granger CB et al. Nature cardiovascular research (2026)
[93]
Periodontal therapy among patients with cardiovascular disease: exploring its association with lower medical spending. — Santoro M, McLeod C, Heaton LJ, Cheung HJ, O'Malley JJ, Vinson M et al. Frontiers in public health (2026)
[94]
Common clonal hematopoiesis driver mutations have disparate effects on macrophage cytokines, clonal expansion, and atherogenesis. — Carter PR, Kitt L, Rodgers AC, Figg N, Zhou A, Zhu C et al. JCI insight (2026)
[95]
Low levels of atherogenic lipoproteins and incident atherosclerotic cardiovascular disease: A pooled cohort primary prevention study. — Faridi KF, Quispe R, Martin SS, Jones SR, Blumenthal RS, Saeed A et al. American heart journal (2026)
[96]
Alterations in cardiovascular biomarkers and gut microbiome associated with night shift work: Insights from the Chinese platform workers study. — Yan T, Rong L, Wang S, Song X, Hu B, Wang Z et al. Environmental research (2026)
[97]
Characterisation of thigh-based electrocardiography (ECG) across different pathologies. — Dos Santos Silva A, Correia MV, da Costa AG, Cerqueira RJ, da Silva HP Scientific reports (2026)
[98]
Correlations between the cumulative metabolic score for visceral fat and its dynamic trajectories with the onset of cardiovascular disease in middle-aged and older adults: findings from two prospective cohorts. — Xu L, Sun M The aging male : the official journal of the International Society for the Study of the Aging Male (2026)
[99]
NAMing the challenges and opportunities of new approach methodologies for studying cardiovascular metabolism. — Caudal A, Wu JC Cell metabolism (2026)
[100]
Sex Differences in the Adverse Electromechanical Remodeling of the Heart After Repeated Witness Stress in Adult Rats: Relationship With a Specific miRNA Signature. — Barbetti M, Bilotti I, Ielpo D, Vilella R, Frati C, Naponelli V et al. Biopsychosocial science and medicine (2026)

Share:Twitter Reddit LinkedIn